Motilal Oswal: Dabur India’s Strong All-Round Performance Augurs Well For Future
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Motilal Oswal Report
Dabur India Ltd. reported a significant beat on the topline and volumes (third highest growth in the past 50 quarters).
The Healthcare portfolio fared even better in Q2 FY21 (49.3% YoY growth) versus Q1 FY21 (27.7% growth).
Notably, the company surprised in the home and personal care and food and beverage segments—HPC reported 9.1% YoY growth in Q2 FY21 (14.1% decline in Q1 FY21), and decline in F&B was restricted to 3.8% YoY (34.2% decline in Q1 FY21 and weak numbers for several preceding quarters).
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the brokerage and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.